Amgen maintained at equal weight by Morgan Stanley
Morgan Stanley maintained its Equal-Weight rating on Amgen, according to Benzinga’s ratings-action roundup.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Amgen maintained at Equal Weight by Morgan Stanley
Morgan Stanley maintained Amgen at Equal-Weight and cut its price target to $359 from $362, per Benzinga.